Published in J Microencapsul on February 02, 2001
N-Succinyl-chitosan nanoparticles coupled with low-density lipoprotein for targeted osthole-loaded delivery to low-density lipoprotein receptor-rich tumors. Int J Nanomedicine (2014) 0.81
Studies on tolfenamic acid-chitosan intermolecular interactions: effect of pH, polymer concentration and molecular weight. AAPS PharmSciTech (2013) 0.81
Preliminary pharmacology of galactosylated chitosan/5-fluorouracil nanoparticles and its inhibition of hepatocellular carcinoma in mice. Cancer Biol Ther (2012) 0.75
Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery. Saudi Pharm J (2012) 0.75
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01
Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Asoc Med P R (1990) 1.79
Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion. Am J Pathol (1974) 1.59
Localization of platelet prostaglandin production in the platelet dense tubular system. Am J Pathol (1976) 1.40
Investigation of the release reaction in platelets exposed to phorbol myristate acetate. Am J Pathol (1974) 1.39
Effects of the lonophore A23187 on the blood platelets II. Influence on ultrastructure. Am J Pathol (1974) 1.27
Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med (1980) 1.23
Influence of epinephrine on the aggregation response of aspirin-treated platelets. Prostaglandins Med (1980) 1.18
Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol (1975) 1.12
Measurement of ionized calcium in blood platelets with a new generation calcium indicator. Biochem Biophys Res Commun (1985) 1.07
An actin-binding protein in human platelets. Interactions with alpha-actinin on gelatin of actin and the influence of cytochalasin B. Am J Pathol (1978) 1.07
Use of plasma glow for surface-engineering biomolecules to enhance bloodcompatibility of Dacron and PTFE vascular prosthesis. Biomaterials (2000) 1.06
Labile aggregation stimulating substance (LASS): the factor from storage pool deficient platelets correcting defective aggregation and release of aspirin treated normal platelets. Br J Haematol (1975) 1.05
Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Studies of the dose-response relationship and mechanism of action in dogs. Am J Pathol (1978) 1.03
Influence of the ionophore A23187 on the plastic behavior of normal erythrocytes. Am J Pathol (1977) 1.03
Surface-activated bovine platelets do not spread, they unfold. Am J Pathol (1990) 0.99
Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions. Thromb Res (1986) 0.99
Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. Am J Pathol (1998) 0.99
Effects of a microtubule stabilizing agent on the response of platelets to vincristine. Blood (1982) 0.97
Recycling of platelet phosphorylation and cytoskeletal assembly. J Cell Biol (1984) 0.96
Influence of a microtubule stabilizing agent on platelet structural physiology. Am J Pathol (1983) 0.93
Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function. Biochem Biophys Res Commun (1983) 0.92
Transcatheter closure of patent foramen ovale for hypoxemia during left ventricular assist device support. J Heart Lung Transplant (1999) 0.91
Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin. Arteriosclerosis (1983) 0.91
Arachidonate-induced platelet aggregation in the dog. Thromb Res (1979) 0.90
Epinephrine potentiation of arachidonate-induced aggregation of cyclooxygenase-deficient platelets. Am J Hematol (1981) 0.90
An improved method for the extraction of endogenous platelet serotonin. J Lab Clin Med (1976) 0.89
Antisterility and antivitamin K activity of d-alpha-tocopheryl hydroquinone in the vitamin E-deficient female rat. J Nutr (1975) 0.89
Interleukin 1 stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanism. Thromb Haemost (1986) 0.88
Human platelet activation by an alkylacetyl analogue of phosphatidylcholine. Biochim Biophys Acta (1982) 0.88
The influence of glutathione depleting agents on human platelet function. Thromb Res (1989) 0.87
The influence of reserpine and ethylenediaminetetraacetic acid (EDTA) on serotonin storage organelles of blood platelets. Am J Pathol (1977) 0.86
Platelet storage pool deficiency and prostaglandin synthesis in chronic granulocytic leukaemia. Br J Haematol (1978) 0.84
Modification of human platelet response to sodium arachidonate by membrane modulation. Prostaglandins Med (1981) 0.83
Effects of 2,2'-dipyridyl and related compounds on platelet prostaglandin synthesis and platelet function. Biochim Biophys Acta (1980) 0.83
Glutathione levels in human platelets display a circadian rhythm in vitro. Thromb Res (1985) 0.82
Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation. Artif Organs (1999) 0.82
Influence of the calcium-sensitive fluorophore, Quin 2, on platelet function. Blood (1986) 0.82
Influence of pH on the prostacyclin (PGI2) mediated inhibition of platelet function. Prostaglandins Med (1980) 0.82
Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dog. Blood (1980) 0.82
Platelet aggregation independent of ADP release or prostaglandin synthesis in patients with hermansky-Pudlak syndrome. Prostaglandins Med (1981) 0.81
Acute effects of amrinone on regional myocardial and systemic blood flow distribution in the dog. Can J Physiol Pharmacol (1982) 0.81
Hypoxemia after prior cardiac surgery due to interatrial shunting and its treatment with a novel transcatheter occlusion device. Catheter Cardiovasc Interv (1999) 0.81
Changes in pericardial calcification due to antiplatelet agents: in vitro studies. Artif Organs (1998) 0.81
Thermosensitization by increasing intracellular acidity with amiloride and its analogs. Int J Radiat Oncol Biol Phys (1994) 0.80
The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes. Prostaglandins Med (1980) 0.80
Action of guanosine 5'-[beta-thio]diphosphate on thrombin-induced activation and Ca2+ mobilization in saponin-permeabilized and intact human platelets. Biochem J (1988) 0.80
Low dose aspirin, platelet function and prostaglandin synthesis: influence of epinephrine and alpha adrenergic blockade. Prostaglandins Med (1981) 0.79
Role of arachidonic acid metabolism in human platelet activation and irreversible aggregation. Am J Hematol (1985) 0.79
Effect of Amrinone, a cardiotonic drug, on hemodynamics and platelet function. Prostaglandins Med (1981) 0.79
Retention of glycoprotein Ib/IX receptors on external surfaces of thrombin-activated platelets in suspension. Blood (1995) 0.79
Phospholipase A2 activation in human neutrophils requires influx of extracellular Ca2+ and leukotriene B4. Am J Physiol (1995) 0.79
Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies. Drug Deliv (2001) 0.79
Smoking and platelet labile aggregation stimulating substance (LASS) synthesizing activity. Thromb Res (1976) 0.79
Inhibition of prostaglandin (PG) synthesis in sheep vesicular gland microsomes (SVGM) by nitroblue tetrazolium (NBT) and vitamin E (VE). Prostaglandins Med (1979) 0.79
Irreversible platelet aggregation does not depend on lipoxygenase metabolites. Biochem Biophys Res Commun (1985) 0.79
Effect of acetaminophen and salicylate on aspirin-induced inhibition of human platelet cyclo-oxygenase. Prostaglandins Leukot Med (1982) 0.79
Influence of esterase inhibitors on platelet aggregation and release induced by phorbol myristate acetate. Biochem Pharmacol (1975) 0.78
Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion. Am J Pathol (1977) 0.78
Development of poly(Lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis. Drug Deliv (2001) 0.78
The influence of vitamin E quinone on platelet structure, function, and biochemistry. Blood (1980) 0.78
Functional platelets after storage in vitro for 15--21 days. Am J Pathol (1980) 0.78
Keratoacanthoma of the conjunctiva complicating xeroderma pigmentosum. Indian J Dermatol Venereol Leprol (2006) 0.78
The role of iron in prostaglandin synthesis: ferrous iron mediated oxidation of arachidonic acid. Prostaglandins Med (1978) 0.78
Aspirin treatment reduces platelet resistance to deformation. Arteriosclerosis (1987) 0.77
Inhibition of platelet aggregation by novel triphenylethylene analogs. Thromb Res (1986) 0.77
Disaggregation and reaggregation of 'irreversibly' aggregated platelets: a method for more complete evaluation of anti-platelet drugs. Agents Actions (1985) 0.77
Comparative pharmacology of cyclooxygenase inhibitors on platelet function. Prostaglandins Leukot Med (1985) 0.77
Signal transduction, second messengers, and platelet function. J Lab Clin Med (1993) 0.77
Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium. Prostaglandins Med (1980) 0.77
Tranylcypromine induced hypertension is not mediated by the inhibition of prostacyclin synthesis. Prostaglandins Med (1979) 0.77
Problem with aspirin as antithrombotic agent in coronary artery disease. Lancet (1988) 0.77
Enteric-coated aspirin, platelet cyclooxygenase activity and function. Prostaglandins Leukot Med (1984) 0.77
Evaluation of heparin immobilized chitosan-PEG microbeads for charcoal encapsulation and endotoxin removal. Artif Cells Blood Substit Immobil Biotechnol (2000) 0.77
Proceedings: Differences in platelet storage pool deficiency (SPD) of Hermansky Pudlak syndrome (HPS) and non-albinos (NA). Thromb Diath Haemorrh (1975) 0.76
Physiologic assessment of the coronary collateral circulation in transplanted human hearts. J Heart Lung Transplant (1995) 0.76
Vessel wall arachidonate metabolism after angioplasty: possible mediators of postangioplasty vasospasm. Am J Cardiol (1983) 0.76
Inhibition of ferrous iron induced oxidation of arachidonic acid by indomethacin. Prostaglandins Med (1979) 0.76
Platelet function in adolescent idiopathic scoliosis. Spine (Phila Pa 1976) (1992) 0.76
Differential sensitivity of regional vascular beds in the dog to low-dose prostacyclin infusion. Can J Physiol Pharmacol (1980) 0.76
Platelet adhesion to novel phospholipid materials: modified phosphatidylcholine covalently immobilized to silica, polypropylene, and PTFE materials. J Biomed Mater Res (1996) 0.76
Reduction of heme by lipid peroxides and its potential relevance to understanding control of cyclo-oxygenase activity. Prog Lipid Res (1981) 0.76
Rapid return of cyclo-oxygenase active platelets in dogs after a single oral dose of aspirin. Prostaglandins (1981) 0.76
Influx of extracellular calcium and agonist-coupling appear essential for the activation of thromboxane A2-dependent phospholipase A2 in human platelets. Prostaglandins Leukot Essent Fatty Acids (1995) 0.75
Epinephrine and platelet function. J Lab Clin Med (1997) 0.75
Failure of devices used for the closure of atrial septal defects. J Thorac Cardiovasc Surg (1997) 0.75
Role of platelet adhesion and aggregation in thrombus formation. Thromb Haemost (1998) 0.75
Percutaneous balloon mitral valvuloplasty in juvenile rheumatic mitral stenosis. Am J Cardiol (1991) 0.75
The influence of metabolities on the assay of platelet serotonin. Thromb Res (1977) 0.75
Epinephrine reduction of heme: implication for understanding the transmission of an agonist stimulus. Science (1982) 0.75
Rapid separation of platelet nucleotides by reversed-phase, isocratic, high-performance liquid chromatography with a radially compressed column. J Chromatogr (1981) 0.75
Simple method for the separation of monohydroxy fatty acid metabolites of arachidonate metabolism. J Chromatogr (1982) 0.75
1,3-Dioctanoylglycerol (1,3-DiC8) is as effective as 1,2-dioctanoylglycerol (1,2-DiC8) in priming phospholipase A2 activation in human platelets and neutrophils. Biochem Med Metab Biol (1994) 0.75
Nitroprusside inhibits platelet function primarily by inhibiting Ca2+ mobilization. Biochem Soc Trans (1990) 0.75
Detergent-resistant cytoskeleton of the surface-activated platelet differs from the suspension-activated platelet cytoskeleton. Blood (1992) 0.75
Rapid separation of nucleotides from granulocytes by isocratic, reversed-phase high-performance liquid chromatography. J Chromatogr (1982) 0.75
Alpha tocopherol quinone (alpha TQ): a potent inhibitor of platelet function. Prog Lipid Res (1981) 0.75
Differential effects of phorbol 12-myristate 13-acetate and diacylglycerols on thromboxane A2-independent phospholipase A2 activation in collage-stimulated human platelets. Biochem Med Metab Biol (1994) 0.75